Perrigo ROA 2010-2023 | PRGO
Perrigo ROA - Return on Assets Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Total Assets | Return on Assets |
2023-12-31 | $-0.01B | $10.81B | -0.12% |
2023-09-30 | $-0.01B | $10.76B | -0.05% |
2023-06-30 | $-0.07B | $10.97B | -0.62% |
2023-03-31 | $-0.14B | $10.96B | -1.29% |
2022-12-31 | $-0.14B | $11.02B | -1.30% |
2022-09-30 | $-0.11B | $10.68B | -1.00% |
2022-06-30 | $-0.12B | $10.92B | -1.09% |
2022-03-31 | $-0.11B | $10.39B | -1.01% |
2021-12-31 | $-0.07B | $10.43B | -0.63% |
2021-09-30 | $-0.25B | $10.92B | -2.26% |
2021-06-30 | $-0.35B | $11.23B | -3.07% |
2021-03-31 | $-0.23B | $11.33B | -1.99% |
2020-12-31 | $-0.16B | $11.49B | -1.40% |
2020-09-30 | $-0.01B | $11.58B | -0.06% |
2020-06-30 | $0.24B | $12.13B | 2.08% |
2020-03-31 | $0.19B | $11.40B | 1.65% |
2019-12-31 | $0.15B | $11.30B | 1.29% |
2019-09-30 | $0.25B | $11.31B | 2.20% |
2019-06-30 | $0.09B | $11.43B | 0.78% |
2019-03-31 | $0.11B | $11.12B | 1.03% |
2018-12-31 | $0.13B | $10.98B | 1.17% |
2018-09-30 | $0.12B | $10.94B | 1.07% |
2018-06-30 | $0.24B | $11.23B | 2.03% |
2018-03-31 | $0.13B | $11.64B | 1.10% |
2017-12-31 | $0.12B | $11.63B | 0.97% |
2017-09-30 | $-1.31B | $11.84B | -10.19% |
2017-06-30 | $-2.95B | $11.79B | -21.23% |
2017-03-31 | $-3.41B | $13.98B | -22.00% |
2016-12-31 | $-4.01B | $13.87B | -23.76% |
2016-09-30 | $-2.83B | $15.89B | -15.48% |
2016-06-30 | $-0.98B | $18.29B | -5.08% |
2016-03-31 | $-0.46B | $19.50B | -2.37% |
2015-12-31 | $0.04B | $19.35B | 0.23% |
2015-09-30 | $0.29B | $19.70B | 1.59% |
2015-06-30 | $0.12B | $19.72B | 0.74% |
2014-12-31 | $0.21B | $16.46B | 1.48% |
2014-09-30 | $0.06B | $13.78B | 0.42% |
2013-12-31 | $0.14B | $13.71B | 1.89% |
2013-09-30 | $0.33B | $5.51B | 6.70% |
2012-12-31 | $0.33B | $4.29B | 7.96% |
2012-09-30 | $0.32B | $4.12B | 7.99% |
2011-12-31 | $0.26B | $3.94B | 7.57% |
2011-09-30 | $0.25B | $3.51B | 7.86% |
2010-12-31 | $0.23B | $2.94B | 8.00% |
2010-09-30 | $0.20B | $2.77B | 7.28% |
2009-12-31 | $0.16B | $2.46B | 6.51% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $4.328B | $4.656B |
Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $186.584B | 24.49 |
Stryker (SYK) | United States | $127.690B | 31.66 |
Boston Scientific (BSX) | United States | $107.347B | 34.19 |
Medtronic (MDT) | Ireland | $105.881B | 14.99 |
EssilorLuxottica (ESLOY) | France | $98.566B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $43.036B | 0.00 |
Haleon (HLN) | United Kingdom | $38.584B | 30.18 |
ResMed (RMD) | United States | $32.074B | 30.08 |
Terumo (TRUMY) | Japan | $24.746B | 34.95 |
Zimmer Biomet Holdings (ZBH) | United States | $24.522B | 15.79 |
Baxter (BAX) | United States | $20.379B | 14.86 |
Koninklijke Philips (PHG) | Netherlands | $19.567B | 15.61 |
Insulet (PODD) | United States | $11.637B | 61.10 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.689B | 0.00 |
Demant (WILYY) | Denmark | $9.943B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.869B | 23.44 |
BellRing Brands (BRBR) | United States | $7.379B | 39.68 |
Haemonetics (HAE) | United States | $4.621B | 23.63 |
Lantheus Holdings (LNTH) | United States | $4.494B | 11.60 |
GN Store Nord (GNNDY) | Denmark | $4.065B | 26.32 |
Envista Holdings (NVST) | United States | $3.504B | 13.33 |
Prestige Consumer Healthcare (PBH) | United States | $3.499B | 16.54 |
QuidelOrtho (QDEL) | United States | $2.651B | 9.62 |
Neogen (NEOG) | United States | $2.630B | 25.29 |
Green Thumb Industries (GTBIF) | United States | $2.571B | 81.47 |
ICU Medical (ICUI) | United States | $2.311B | 17.24 |
TG Therapeutics (TGTX) | United States | $2.082B | 673.50 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.936B | 0.00 |
Owens & Minor (OMI) | United States | $1.922B | 18.45 |
Agios Pharmaceuticals (AGIO) | United States | $1.770B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.697B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $1.469B | 48.49 |
InMode (INMD) | Israel | $1.439B | 7.45 |
National Vision Holdings (EYE) | United States | $1.400B | 43.61 |
AdaptHealth (AHCO) | United States | $1.324B | 9.96 |
Warby Parker (WRBY) | United States | $1.271B | 0.00 |
AtriCure (ATRC) | United States | $1.121B | 0.00 |
MacroGenics (MGNX) | United States | $0.911B | 0.00 |
Canopy Growth (CGC) | Canada | $0.893B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.794B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.709B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.682B | 14.73 |
Evolus (EOLS) | United States | $0.662B | 0.00 |
Jin Medical (ZJYL) | China | $0.626B | 0.00 |
Quanterix (QTRX) | United States | $0.595B | 0.00 |
Valneva SE (VALN) | France | $0.532B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.516B | 11.17 |
PetIQ (PETQ) | United States | $0.486B | 18.16 |
TerrAscend (TSNDF) | Canada | $0.486B | 0.00 |
ZimVie (ZIMV) | United States | $0.431B | 26.37 |
Biote (BTMD) | United States | $0.411B | 3.91 |
OraSure Technologies (OSUR) | United States | $0.407B | 6.73 |
Surmodics (SRDX) | United States | $0.373B | 40.26 |
Aurora Cannabis (ACB) | Canada | $0.365B | 0.00 |
Zynex (ZYXI) | United States | $0.361B | 41.52 |
Viemed Healthcare (VMD) | United States | $0.322B | 31.96 |
Cerus (CERS) | United States | $0.310B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.279B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.250B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.237B | 14.65 |
Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
Veru (VERU) | United States | $0.186B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.183B | 0.00 |
Omeros (OMER) | United States | $0.183B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.170B | 0.00 |
High Tide (HITI) | Canada | $0.161B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.156B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.144B | 72.36 |
FitLife Brands (FTLF) | United States | $0.132B | 21.28 |
Jushi Holdings (JUSHF) | United States | $0.131B | 0.00 |
InterCure (INCR) | Israel | $0.121B | 20.46 |
Fonar (FONR) | United States | $0.103B | 8.84 |
MariMed (MRMD) | United States | $0.100B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.100B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.098B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.092B | 0.00 |
Safety Shot (SHOT) | United States | $0.082B | 0.00 |
Chimerix (CMRX) | United States | $0.080B | 0.00 |
Brainsway (BWAY) | Israel | $0.079B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.058B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.054B | 3.53 |
Apyx Medical (APYX) | United States | $0.050B | 0.00 |
Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
ImmuCell (ICCC) | United States | $0.040B | 0.00 |
United-Guardian (UG) | United States | $0.038B | 14.77 |
Bright Green (BGXX) | United States | $0.038B | 0.00 |
Modular Medical (MODD) | United States | $0.035B | 0.00 |
Exagen (XGN) | United States | $0.024B | 0.00 |
Nephros (NEPH) | United States | $0.023B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.019B | 0.00 |
Flora Growth (FLGC) | United States | $0.017B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
Agape ATP (ATPC) | $0.017B | 0.00 | |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
GlucoTrack (GCTK) | United States | $0.012B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 71.82 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |